Hexima
  • Home
  • About
    • About Hexima
    • Management Team
    • Board of Directors
  • Products
    • HXP124
    •   > Clinical Trials
  • Technology
    • Antifungal Plant Defensins
  • Publications
    • Peer Reviewed Papers
    • Posters and Presentations
    • Patents
    • Hexima in the Media
  • Investors
    • Corporate Governance
    • Announcements
    • Annual & Interim Reports
    • Share Price
    • Investor Services
    • Investor Contacts
  • Contact
Select Page

Hexima – To Seize Early Position In Nascent Multi Billion Dollar Biotech Seed Industry – Bioshares

Jul 4, 2009 | Hexima news, News, Publications

The high level of active discussion over the role of genetically modified food crops over the last 10 years could cause one to believe that genetically modified (GM) plant technologies have been around for decades… View article Hexima – Bioshares July...

Hexima’s Next Generation of Science Leadership

Jul 3, 2009 | Hexima news, News

View Next-Generation-of-Science-Leadership

Hexima and ACPFG announce strategic alliance focused on cereals

Apr 11, 2009 | Hexima news, News

View Release Hexima and ACPFG Alliance

Through the Glasshouse: Hexima’s Stylish Resistance

Mar 3, 2009 | Hexima news, News, Publications

Agbiotech often sails under the radar, but Melbourne company Hexima has been making waves with its fungal and insect-resistance technology, and with its deal with Pioneer Hi-Bred International, the agricultural business unit of multinational DuPont. Kate McDonald...

Dow AgroSciences and Hexima Collaborate on Cotton Seed Development

Aug 27, 2008 | Hexima news, News

Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company, is collaborating with Hexima Limited to test cotton plants using Dow AgroSciences propriatary genetic constructs. View Release Hexima and Dow AgroSciences Collaborate

DuPont and Hexima partner to develop and commercialize Fungal Disease Resistance Technology

Aug 7, 2008 | Hexima news, News

DuPont and Hexima today announced a development and commercialization agreement for certain biotech fungal disease resistance technology in corn, soybean and other crops. View Release Hexima and DuPont Partner
« Older Entries
Next Entries »

Archives

Categories

Site Search

About us

Hexima is a biotechnology company actively engaged in the research and development of plant-derived proteins and peptides for applications as human therapeutics.

Contact

La Trobe Institute for Molecular Science
Level 4, LIMS2
La Trobe University VIC 3086
Australia

Phone: +61 3 9479 1210

Stay up to date

For the latest shareholder information & investor news, subscribe to our email alerts.

  • RSS

Site Design: Paraph. Hosting, updates & security: 4tify